Bernal, T
Martínez-Camblor, P
Sánchez-García, J
Sanz, G
Article History
First Online: 12 January 2016
Competing interests
: TB has served as advisory board member and consultant for Celgene and has received speaker fees. GS has received honoraria and research funding from Celgene, Novartis and Amgen, and is on the advisory committee for Amgen, Böehringer-Ingelheim, Celgene, MerckSharp and Dohme, and Novartis. The Spanish Group on Myelodysplastic Syndromes is sponsored by Celgene and Novartis.